Literature DB >> 5431453

The mechanism of action of aminophylline upon cerebral vascular disorders.

E Skinhoj, O B Paulson.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 5431453     DOI: 10.1111/j.1600-0404.1970.tb05612.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


× No keyword cloud information.
  11 in total

Review 1.  Drug treatment of stroke. Current status and future prospects.

Authors:  C A Sila; A J Furlan
Journal:  Drugs       Date:  1988-04       Impact factor: 9.546

Review 2.  Clinical pharmacokinetics of theophylline.

Authors:  R I Ogilvie
Journal:  Clin Pharmacokinet       Date:  1978 Jul-Aug       Impact factor: 6.447

3.  [Influence of bencyclan on regional cerebral blood flow in patients with insufficient cerebral blood flow (author's transl)].

Authors:  H Herschaft; F Gleim; P Duus
Journal:  Klin Wochenschr       Date:  1974-05-15

4.  The role of cerebral blood flow for the recovery of the brain after prolonged ischemia.

Authors:  K A Hossmann; H Lechtape-Grüter; V Hossmann
Journal:  Z Neurol       Date:  1973

5.  Neuronal injury in the infarct border: a neuropathological study in the rat.

Authors:  M Nedergaard
Journal:  Acta Neuropathol       Date:  1987       Impact factor: 17.088

Review 6.  Theophylline, aminophylline, caffeine and analogues for acute ischaemic stroke.

Authors:  P M W Bath
Journal:  Cochrane Database Syst Rev       Date:  2004

7.  Effect of nimodipine (Bay e 9736) on postischaemic cerebrovascular reactivity, as revealed by measuring regional cerebral blood flow (rCBF).

Authors:  H J Gelmers
Journal:  Acta Neurochir (Wien)       Date:  1982       Impact factor: 2.216

8.  Birth defects following maternal exposure to ergotamine, beta blockers, and caffeine.

Authors:  H E Hughes; D A Goldstein
Journal:  J Med Genet       Date:  1988-06       Impact factor: 6.318

9.  Theophylline as an add-on to thrombolytic therapy in acute ischaemic stroke (TEA-Stroke): A randomized, double-blinded, placebo-controlled, two-centre phase II study.

Authors:  Boris Modrau; Niels Hjort; Leif Østergaard; Kim Mouridsen; Grethe Andersen; Flemming Winther Bach
Journal:  Eur Stroke J       Date:  2016-10-14

Review 10.  Xanthine scaffold: scope and potential in drug development.

Authors:  Nivedita Singh; Ashwinee Kumar Shreshtha; M S Thakur; Sanjukta Patra
Journal:  Heliyon       Date:  2018-10-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.